EW (Edwards Lifesciences Corp) Gross Margin

Official company branding of Edwards Lifesciences Corp (EW)

Gross margin reflects the result of concentrated development within the cardiac surgery segment, where the value of 78.30 expresses the metric level for Edwards Lifesciences (EW). This trend confirms the company's status as a global leader in creating heart systems. However, logistical disruptions and sanctions in several countries are currently creating barriers to the implementation of this high-tech equipment in isolated regions.

EW: edwards.com Return on Gross Profit 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company Edwards Lifesciences Inc. (EW)

Summary company analysis:Edwards Lifesciences
Signature product of Edwards Lifesciences Corp

Edwards Lifesciences leadership in the Sapien transcatheter valve segment ensures a steady capital inflow and high operational efficiency. This profitability is reflected in the calculation of the difference between total revenue and direct production costs. The metric measures the business's ability to control cost of goods sold and withstand inflationary pressure on raw materials. Analyzing the gross operating margin allows an investor to detect profit erosion in a timely manner or confirm the resilience of the business model.

Direct competitors

BSX - Return on Sales by Gross Profit|RMD (ResMed Corporation) - Gross Margin|OmniPod (PODD) - Return on Sales by Gross Profit|Gross Margin ZBH|Gross Margin coopercos.com (COO)|Gross Margin ALGN (aligntech.com)|Gross Margin Globus Medical Inc GMED|TMDX - Gross Profitability|ATEC: Gross Profitability|AORT (Artivion, Inc.) - Return on Gross Profit|Enovis Corporation - Gross Profit Rate|IART (Integra LifeSciences Inc.) - Gross Margin|Gross Profit Margin Establishment Labs Corp ESTA|Gross Profitability Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO